Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
100 participants
INTERVENTIONAL
2007-09-30
2008-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Treatment of Xerostomia by Herbal Preparation
NCT01579877
Artificial Saliva Containing Cumin and Ginger Extract in Hemodialysis Patients With Xerostomia
NCT06476223
Risk Factors Related to Thirst After Surgery
NCT04900753
Effect of 0.1% Pilocarpine Mouthwash on Xerostomia
NCT01627626
Efficacy of Novel Edible Gel-based Artificial Saliva in Thai Geriatric Populations With Systemic Diseases
NCT02317172
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Worldwide use
* A main herb of old oriental prescriptions for dry mouth
* Need for correct information by RCT
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Korean Red Ginseng group
The brand name of experimental drug is 'Capsule of Korean Red Ginseng Powder'. It consists of the powder of steamed root of Panax ginseng made by Korean Ginseng Corp.
Korean Red Ginseng Powder Capsule
Generic name: Korean Red Ginseng Powder Capsule Original herb name: Panax ginseng Form and contents: Capsule with powder of steamed root of 6-year Panax ginseng Dosage and frequency: 6 g per day (twice a day), Oral administration Administration duration: 56 days in the study
Corn-starch powder with ginseng flavor
The placebo of this study is corn-starch powder with Korean Red Ginseng flavor. It has the same shape, color and flavor like experimental drug.
Corn-starch powder with ginseng flavor
There is no specific name because this intervention is placebo. This placebo has the same form, color and flavor as Korean Red Ginseng Powder Capsule.
The dosage form, dosage, frequency and duration is also same as experimental intervention (Korean Red Ginseng Powder Capsule).
Main contents: corn-starch with Panax ginseng flavor
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Korean Red Ginseng Powder Capsule
Generic name: Korean Red Ginseng Powder Capsule Original herb name: Panax ginseng Form and contents: Capsule with powder of steamed root of 6-year Panax ginseng Dosage and frequency: 6 g per day (twice a day), Oral administration Administration duration: 56 days in the study
Corn-starch powder with ginseng flavor
There is no specific name because this intervention is placebo. This placebo has the same form, color and flavor as Korean Red Ginseng Powder Capsule.
The dosage form, dosage, frequency and duration is also same as experimental intervention (Korean Red Ginseng Powder Capsule).
Main contents: corn-starch with Panax ginseng flavor
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Irradiation related xerostomia
* Severe psychiatric diseases
* pregnancy or breast feeding women
19 Years
76 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Korean Society of Ginseng
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kyung Hee East-West Neo Medical Center
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jae-Woo Park, K.M.D., Ph.D
Role: PRINCIPAL_INVESTIGATOR
Kyung Hee East-West Neo Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kyung Hee East-West Neo Medical Center
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KHNMC-OH-IRB 2007-007
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.